Page last updated: 2024-11-08

trilobine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trilobine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169007
CHEMBL ID500324
CHEBI ID9723
SCHEMBL ID2980757
MeSH IDM0122249

Synonyms (18)

Synonym
trilobine
6138-73-4
C09669
CHEMBL500324
(+)-n-methyltelobine
chebi:9723 ,
unii-6h8v6c2q77
6h8v6c2q77 ,
oxyacanthan, 6',7-epoxy-6,12'-dimethoxy-2'-methyl-, (1'alpha)-
2h-22,26-epoxy-1,24:12,15-dietheno-6,10-metheno-16h-pyrido(2',3':17,18)(1,10)dioxacycloeicosino(2,3,4-ij)isoquinoline, 3,4,4a,5,16a,17,18,19-octahydro-9,21-dimethoxy-4-methyl-, (4as,16as)-
(4as,16as)-3,4,4a,5,16a,17,18,19-octahydro-9,21-dimethoxy-4-methyl-2h-12,26-epoxy-1,24:22,15-dietheno-6,10-metheno-16h-pyrido(2':3':17,18)(1,10)dioxacycloeicosino(2,3,4-ij)isoquinoline
trilobine [mi]
SCHEMBL2980757
AKOS024269944
Q27108483
6,12'-dimethoxy-2'-methyl-6',7-epoxyoxyacanthan
DTXSID90976922
(8s,21s)-13,27-dimethoxy-7-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.216,19.14,30.110,14.03,8.025,33.028,32]heptatriaconta-1(30),2,4(34),10(37),11,13,16,18,25,27,32,35-dodecaene

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID332123Reversal of P-gp-mediated multidrug resistance in human MCF/ADR cells assessed as ratio of doxorubicin ED50 without drug to doxorubicin ED50 with drug at 0.8 ug/ml after 6 days by BCA assay1997Journal of natural products, Nov, Volume: 60, Issue:11
Multidrug-resistance modulators from Stephania japonica.
AID332122Reversal of P-gp-mediated multidrug resistance in human MCF/ADR cells assessed as ratio of doxorubicin ED50 without drug to doxorubicin ED50 with drug at 1.0 ug/ml after 6 days by BCA assay1997Journal of natural products, Nov, Volume: 60, Issue:11
Multidrug-resistance modulators from Stephania japonica.
AID377946Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-sensitive Plasmodium falciparum D61999Journal of natural products, Jan, Volume: 62, Issue:1
Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids.
AID377947Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs1999Journal of natural products, Jan, Volume: 62, Issue:1
Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids.
AID377944Cytotoxicity against human KB cells after 72 hrs by SRB assay1999Journal of natural products, Jan, Volume: 62, Issue:1
Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids.
AID332124Reversal of P-gp-mediated multidrug resistance in human MCF/ADR cells assessed as ratio of doxorubicin ED50 without drug to doxorubicin ED50 with drug at 0.6 ug/ml after 6 days by BCA assay1997Journal of natural products, Nov, Volume: 60, Issue:11
Multidrug-resistance modulators from Stephania japonica.
AID377948Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-sensitive Plasmodium falciparum W21999Journal of natural products, Jan, Volume: 62, Issue:1
Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids.
AID332125Reversal of P-gp-mediated multidrug resistance in human MCF/ADR cells assessed as ratio of doxorubicin ED50 without drug to doxorubicin ED50 with drug at 0.3 ug/ml after 6 days by BCA assay1997Journal of natural products, Nov, Volume: 60, Issue:11
Multidrug-resistance modulators from Stephania japonica.
AID377945Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as [3H]hypoxanthine uptake after 24 hrs1999Journal of natural products, Jan, Volume: 62, Issue:1
Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (83.33)18.7374
1990's3 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.98 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]